IPHA
Price
$1.98
Change
-$0.03 (-1.49%)
Updated
Apr 25 closing price
Capitalization
167.56M
15 days until earnings call
VALN
Price
$7.03
Change
+$0.04 (+0.57%)
Updated
Apr 25 closing price
Capitalization
597.1M
9 days until earnings call
Ad is loading...

IPHA vs VALN

Header iconIPHA vs VALN Comparison
Open Charts IPHA vs VALNBanner chart's image
Innate Pharma SA
Price$1.98
Change-$0.03 (-1.49%)
Volume$29.17K
Capitalization167.56M
Valneva SE
Price$7.03
Change+$0.04 (+0.57%)
Volume$10.86K
Capitalization597.1M
IPHA vs VALN Comparison Chart
Loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHA vs. VALN commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHA is a StrongBuy and VALN is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (IPHA: $1.98 vs. VALN: $7.03)
Brand notoriety: IPHA and VALN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHA: 59% vs. VALN: 14%
Market capitalization -- IPHA: $167.56M vs. VALN: $597.1M
IPHA [@Biotechnology] is valued at $167.56M. VALN’s [@Biotechnology] market capitalization is $597.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHA’s FA Score shows that 1 FA rating(s) are green whileVALN’s FA Score has 1 green FA rating(s).

  • IPHA’s FA Score: 1 green, 4 red.
  • VALN’s FA Score: 1 green, 4 red.
According to our system of comparison, both IPHA and VALN are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHA’s TA Score shows that 5 TA indicator(s) are bullish while VALN’s TA Score has 5 bullish TA indicator(s).

  • IPHA’s TA Score: 5 bullish, 5 bearish.
  • VALN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VALN is a better buy in the short-term than IPHA.

Price Growth

IPHA (@Biotechnology) experienced а +0.51% price change this week, while VALN (@Biotechnology) price change was +3.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was -3.08%, and the average quarterly price growth was -10.41%.

Reported Earning Dates

IPHA is expected to report earnings on May 13, 2025.

VALN is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VALN($597M) has a higher market cap than IPHA($168M). VALN YTD gains are higher at: 60.796 vs. IPHA (7.609).
IPHAVALNIPHA / VALN
Capitalization168M597M28%
EBITDAN/A21.2M-
Gain YTD7.60960.79613%
P/E RatioN/AN/A-
RevenueN/A159M-
Total CashN/A156M-
Total DebtN/A201M-
TECHNICAL ANALYSIS
Technical Analysis
IPHAVALN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 21 days ago
84%
Bearish Trend 17 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
N/A
View a ticker or compare two or three
Ad is loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSTIX12.290.18
+1.49%
Goldman Sachs Strategic Growth Instl
MUIFX29.140.18
+0.62%
Nationwide Institutional Service
IHSAX18.070.05
+0.28%
Hartford Small Company A
CRMEX5.97N/A
N/A
CRM All Cap Value Inv
AEIUX8.34-0.02
-0.24%
American Century Equity Income R5

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
-1.49%
MDGL - IPHA
43%
Loosely correlated
+2.14%
SLNO - IPHA
34%
Loosely correlated
-1.31%
VALN - IPHA
30%
Poorly correlated
+0.57%
QSI - IPHA
28%
Poorly correlated
+0.82%
VKTX - IPHA
27%
Poorly correlated
-2.61%
More